VERU-111, a novel oral inhibitor of α and β tubulin,...

European Urology Supplements 2019 / 03 Vol. 18; Iss. 1

VERU-111, a novel oral inhibitor of α and β tubulin, inhibits tumor growth in the human castration-resistant AR variant prostate cancer (PCa) model 22Rv1

Getzenberg, R., Markowski, M.M., Eisenberger, M.A., Steiner, M.S., Antonarakis, E.S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)30976-5
Date:
March, 2019
File:
PDF, 86 KB
english, 2019
Conversion to is in progress
Conversion to is failed